Bill Ackman

Bill Ackman Pershing Square Capital Management

AUM $13.7B
 

Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.

This Quarter Return
+0.03%
1 Year Return
+21.24%
3 Year Return
+111.22%
5 Year Return
+180.66%
10 Year Return
+335.37%
AUM
$14.4B
AUM Growth
+$14.4B
Cap. Flow
-$401M
Cap. Flow %
-2.78%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

1
AGN
Allergan plc
AGN
$401M

Sector Composition

1 Healthcare 43.91%
2 Materials 27.03%
3 Industrials 15.46%
4 Consumer Discretionary 10.05%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BHC icon
1
Bausch Health
BHC
$2.7B
$4.33B 29.95% 19,473,933
APD icon
2
Air Products & Chemicals
APD
$65.4B
$2.81B 19.46% 20,549,076
CP icon
3
Canadian Pacific Kansas City
CP
$70B
$2.23B 15.46% 13,940,890
ZTS icon
4
Zoetis
ZTS
$68.9B
$2.02B 13.96% 41,823,145
QSR icon
5
Restaurant Brands International
QSR
$20.6B
$1.45B 10.05% 38,003,984
ESI icon
6
Element Solutions
ESI
$6.22B
$1.09B 7.57% 42,737,394
HHH icon
7
Howard Hughes
HHH
$4.5B
$512M 3.55% 3,568,017
AGN
8
DELISTED
Allergan plc
AGN
-1,348,358 Closed -$401M